C Scholz
31.03.2016
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
Janni W, Friedl T, Zwingers T, Huober J, Scholz C, Annecke K, Wischnik A, Jueckstock J, Augustin D, Rack B, Harbeck N, Kiechle M. Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study. Br J Cancer 2016; 114:863-71.
31.03.2016Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
31.03.2016Br J Cancer 2016; 114:863-71
Janni W, Friedl T W P, Zwingers T, Huober Jens, Scholz C, Annecke K, Wischnik A, Jueckstock J, Augustin D, Rack B, Harbeck N, Kiechle M
Weiter
25.06.2013
First experience using navigation-guided radiofrequency kyphoplasty for sacroplasty in sacral insufficiency fractures
Klingler J, Kluge P, Sircar R, Kogias E, Scholz C, Krüger M, Scheiwe C, Hubbe U. First experience using navigation-guided radiofrequency kyphoplasty for sacroplasty in sacral insufficiency fractures. Rofo 2013; 185:733-40.
25.06.2013First experience using navigation-guided radiofrequency kyphoplasty for sacroplasty in sacral insufficiency fractures
25.06.2013Rofo 2013; 185:733-40
Klingler J-H, Kluge P, Sircar R, Kogias Evangelos, Scholz C, Krüger M T, Scheiwe C, Hubbe U
Weiter